Trial intelligence / Profile preview

Exparel vs Ropivacaine for Pain Relief After Total Knee Arthroplasty

NCT02607579Unknown

Sponsor
Monmouth Medical Center
Start
Jan 2015
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Monmouth Medical Center. Primary endpoint: Pain relief. Status: unknown.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02607579.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02607579.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call